Global pharmaceutical giant Lilly has partnered with Indian healthcare leader Cipla to distribute the diabetes medication Yurpeak across India. The collaboration is poised to enhance access to innovative treatments for patients managing type 2 diabetes, reflecting a growing trend of strategic alliances between multinational and domestic pharmaceutical companies.